Discovering genes in mammary cancer by insertional mutagenesis

Novel bi-specific TCR-based reagents for targeted cancer immunotherapy

Centrosomes in ovarian cancer

Hallmarks of cancer cell development

Pembrolizumab and indoximod for melanoma

Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030

Nivolumab for NSCLC: five years on

Avelumab for metastatic Merkel cell carcinoma after chemotherapy

Nivolumab and ipilimumab combination for advanced skin cancer

Long-term clinical outcomes and analyses of atezolizumab for mTNBC

Checkmate 067 - combined nivolumab and ipilimumab

Glycemia positively associated with prostate cancer mortality in non-diabetic men